rimantadine has been researched along with Adenomatous Polyposis Coli in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steens, J | 1 |
| Bemelman, WA | 1 |
| Meijerink, WJ | 1 |
| Griffioen, G | 1 |
| van Hogezand, RA | 1 |
| Masclee, AA | 1 |
1 other study available for rimantadine and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
Ileoanal pouch function is related to postprandial pouch tone.
Topics: Adenomatous Polyposis Coli; Adult; Aged; Colitis, Ulcerative; Compliance; Eating; Female; Follow-Up | 2001 |